C
Core One Labs Inc
CNSX:COOL
Core One Labs Inc
CNSX:COOL
Price:
0.145
CAD
Market Closed
Market Cap:
CA$6.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Core One Labs Inc
CNSX:COOL
|
CA |
|
Country Garden Services Holdings Co Ltd
HKEX:6098
|
CN |
|
Steadfast Group Ltd
ASX:SDF
|
AU |
Relative Value
There is not enough data to reliably calculate the relative value of COOL.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
COOL
Relative Value
Base Case
Not Available
C
Multiples Across Competitors
COOL Competitors Multiples
Core One Labs Inc Competitors
Core One Labs Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
C
|
Core One Labs Inc
CNSX:COOL
|
6.8m CAD | 7.3 | -0.3 | -0.7 | -0.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.6 | 15.9 | 22.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
